| London Michelle Muse, MD | |
|
1120 Greene St, Adel, IA 50003-1712 | |
| (515) 993-4656 | |
| (515) 993-4532 |
| Full Name | London Michelle Muse |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 12 Years |
| Location | 1120 Greene St, Adel, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538425129 | NPI | - | NPPES |
| 04218939 | Medicaid | NY |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercyone Des Moines Medical Center | Des moines, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Clinics Inc | 7911810882 | 373 |
News Archive
Scientific progress in Huntington's disease (HD) relies upon the availability of appropriate animal models that enable insights into the disease's genetics and/or pathophysiology.
Should all women in their 40s be routinely screened for breast cancer? Not necessarily, according to the American College of Physicians.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that U.S. gastroenterologists will treat a larger proportion of treatment nonresponder hepatitis C patients with Vertex/Tibotec/Mitsubishi Tanabe's telaprevir than Merck's boceprevir.
Researchers at Suburban Lung Associates and the Chicago Chest Center recently announced the start of the EASE (Exhale Airway Stents for Emphysema) Trial to explore an investigational treatment for advanced widespread emphysema.
› Verified 7 days ago
| Entity Name | Mercy Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457691941 PECOS PAC ID: 7911810882 Enrollment ID: O20031112000238 |
News Archive
Scientific progress in Huntington's disease (HD) relies upon the availability of appropriate animal models that enable insights into the disease's genetics and/or pathophysiology.
Should all women in their 40s be routinely screened for breast cancer? Not necessarily, according to the American College of Physicians.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that U.S. gastroenterologists will treat a larger proportion of treatment nonresponder hepatitis C patients with Vertex/Tibotec/Mitsubishi Tanabe's telaprevir than Merck's boceprevir.
Researchers at Suburban Lung Associates and the Chicago Chest Center recently announced the start of the EASE (Exhale Airway Stents for Emphysema) Trial to explore an investigational treatment for advanced widespread emphysema.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| London Michelle Muse, MD Po Box 1475, Des Moines, IA 50305-1475 Ph: (515) 993-4656 | London Michelle Muse, MD 1120 Greene St, Adel, IA 50003-1712 Ph: (515) 993-4656 |
News Archive
Scientific progress in Huntington's disease (HD) relies upon the availability of appropriate animal models that enable insights into the disease's genetics and/or pathophysiology.
Should all women in their 40s be routinely screened for breast cancer? Not necessarily, according to the American College of Physicians.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that U.S. gastroenterologists will treat a larger proportion of treatment nonresponder hepatitis C patients with Vertex/Tibotec/Mitsubishi Tanabe's telaprevir than Merck's boceprevir.
Researchers at Suburban Lung Associates and the Chicago Chest Center recently announced the start of the EASE (Exhale Airway Stents for Emphysema) Trial to explore an investigational treatment for advanced widespread emphysema.
› Verified 7 days ago
Susan Louise Donahue, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 710 Common Pl Ste 700, Adel, IA 50003 Phone: 515-875-9760 Fax: 515-875-9761 |